BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1096811)

  • 1. Antibacterial activity of cinoxacin in vitro.
    Giamarellou H; Jackson GG
    Antimicrob Agents Chemother; 1975 May; 7(5):688-92. PubMed ID: 1096811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cinoxacin: in vitro antibacterial studies of a new synthetic organic acid.
    Lumish RM; Norden CW
    Antimicrob Agents Chemother; 1975 Feb; 7(2):159-63. PubMed ID: 1094949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antimicrobial activity of cinoxacin against 2,968 clinical bacterial isolates.
    Jones RN; Fuchs PC
    Antimicrob Agents Chemother; 1976 Jul; 10(1):146-9. PubMed ID: 984747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
    Vuye A
    Arzneimittelforschung; 1983; 33(12):1623-7. PubMed ID: 6230083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on cinoxacin. 1. In vitro activity of cinoxacin, as compared to nalidixic acid, against urinary tract pathogens.
    Mårdh PA; Collen S; Andersson KE
    J Antimicrob Chemother; 1977 Sep; 3(5):411-6. PubMed ID: 903323
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative in vitro studies of cinoxacin, nalidixic acid, and oxolinic acid.
    Gordon RC; Stevens LI; Edmiston CE; Mohan K
    Antimicrob Agents Chemother; 1976 Dec; 10(6):918-20. PubMed ID: 12717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cinoxacin: effectiveness against experimental pyelonephritis in rats.
    Holmes DH; Ensminger PW; Gordee RS
    Antimicrob Agents Chemother; 1974 Oct; 6(4):432-6. PubMed ID: 4157340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of cinoxacin, an organic acid antibacterial.
    Kurtz S; Turck M
    Antimicrob Agents Chemother; 1975 Mar; 7(3):370-3. PubMed ID: 1137390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of cinoxacin in urinary tract infections.
    Panwalker AP; Giamarellou H; Jackson GG
    Antimicrob Agents Chemother; 1976 Mar; 9(3):502-5. PubMed ID: 1259405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ["In vitro" and "in vivo" antibacterial activity of a new synthetic antibiotic cinoxacin].
    Ravagnan G; Piccolomini R
    Boll Soc Ital Biol Sper; 1979 Jul; 55(14):1348-54. PubMed ID: 391252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microcalorimetric investigation of the action of cinoxacin against Escherichia coli.
    Mårdh PA; Arhammer M; Colleen S; Andersson KE
    J Antimicrob Chemother; 1978 Jan; 4(1):73-8. PubMed ID: 342483
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro susceptibility of urinary isolates of Escherichia coli to cinoxacin.
    Barnham M; Gaya H
    J Antimicrob Chemother; 1979 Jul; 5(4):413-8. PubMed ID: 385579
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro synergistic activity of some chinolinic compounds combined with beta-lactam antibiotics against gram-positive and gram-negative clinical isolates.
    Ravagnan G; Piccolomini R; Speciale AM; Russo G; Renzini G
    Chemotherapy; 1985; 31(3):191-9. PubMed ID: 3996087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to ten different fluoroquinolone antibiotics following in vitro exposures to nalidixic acid.
    Barry AL; Gardiner RV; Packer RR
    Diagn Microbiol Infect Dis; 1987 Jan; 6(1):77-9. PubMed ID: 3802748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of norfloxacin in synthetic media and human urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.
    Shah PM; Ottnad-Walz M; Stille W
    Methods Find Exp Clin Pharmacol; 1983 Dec; 5(10):731-4. PubMed ID: 6231438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity of norfloxacin.
    Norrby SR; Jonsson M
    Antimicrob Agents Chemother; 1983 Jan; 23(1):15-8. PubMed ID: 6219617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of cinoxacin, ampicillin, and chloramphenicol against Shigella and nontyphoid Salmonella.
    Rubinstein E; Shainberg B
    Antimicrob Agents Chemother; 1977 Apr; 11(4):577-9. PubMed ID: 856008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, primary photophysical and antibacterial properties of naphthyl ester cinoxacin and nalidixic acid derivatives.
    Vargas F; Zoltan T; Rivas C; Ramirez A; Cordero T; Díaz Y; Izzo C; Cárdenas YM; López V; Gómez L; Ortega J; Fuentes A
    J Photochem Photobiol B; 2008 Aug; 92(2):83-90. PubMed ID: 18562206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations.
    Barry AL; Jones RN
    Antimicrob Agents Chemother; 1984 Jun; 25(6):775-7. PubMed ID: 6234858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial activity of ribostamycin on Enterobacteriaceae.
    Yourassowsky E; Vander Linden MP
    Arzneimittelforschung; 1976 Feb; 26(2):184-5. PubMed ID: 779802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.